Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (HKG:9989)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.27
+0.14 (2.73%)
At close: Mar 6, 2026

HKG:9989 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Market Capitalization
17,34215,06016,90519,32027,97028,112
Market Cap Growth
17.55%-10.92%-12.50%-30.93%-0.50%3.28%
Enterprise Value
17,40616,44821,02422,60029,80430,748
Last Close Price
5.273.733.375.027.4410.64
PE Ratio
37.7621.88-23.4994.6323.11
PS Ratio
2.952.692.832.393.584.44
PB Ratio
1.281.161.281.381.982.03
P/TBV Ratio
1.641.491.661.812.622.71
P/FCF Ratio
9.397.10----
P/OCF Ratio
8.616.4538.53--634.89
EV/Sales Ratio
2.852.943.512.793.824.86
EV/EBITDA Ratio
19.8815.05180.7015.7122.0120.11
EV/EBIT Ratio
31.7320.72-20.0229.1325.54
EV/FCF Ratio
9.437.75----
Debt / Equity Ratio
0.250.290.460.520.490.48
Debt / EBITDA Ratio
3.373.3338.644.954.984.28
Debt / FCF Ratio
1.831.78----
Net Debt / Equity Ratio
00.070.270.240.150.17
Net Debt / EBITDA Ratio
0.000.8530.082.371.571.58
Net Debt / FCF Ratio
00.44-81.01-3.08-8.62-11.59
Asset Turnover
0.310.290.270.360.330.31
Inventory Turnover
0.730.580.670.841.111.19
Quick Ratio
1.161.090.760.941.191.52
Current Ratio
2.392.602.132.222.252.53
Return on Equity (ROE)
3.23%5.17%-6.58%5.97%2.01%10.66%
Return on Assets (ROA)
2.22%2.55%-0.68%3.13%2.73%3.70%
Return on Invested Capital (ROIC)
4.21%4.55%-1.42%6.00%6.18%5.98%
Return on Capital Employed (ROCE)
4.70%5.50%-1.50%6.60%5.80%6.60%
Earnings Yield
2.65%4.57%-5.10%4.26%1.06%4.33%
FCF Yield
10.64%14.09%-0.26%-5.73%-0.88%-0.74%
Dividend Yield
5.21%7.13%-2.25%0.58%1.67%
Payout Ratio
68.39%--34.51%171.31%43.69%
Buyback Yield / Dilution
0.56%0.54%-0.67%-0.05%-8.42%-8.51%
Total Shareholder Return
5.77%7.67%-0.67%2.20%-7.84%-6.84%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.